Welcome to our dedicated page for WW International news (Ticker: WW), a resource for investors and traders seeking the latest updates and insights on WW International stock.
WW International, Inc. operates the Weight Watchers weight-management platform through digital, workshop and clinical subscription offerings. Company news commonly covers subscriber trends, subscription revenue, adjusted operating measures and the balance between its Behavioral business and its Clinical business.
Recurring updates also include expansion of the Med+ clinical offering, access to FDA-approved GLP-1 treatment options through affiliated medical groups, debt-reduction actions involving its term loan, and governance changes such as board appointments, committee assignments and interim executive-leadership structure.
WW International (NASDAQ: WW) has appointed Felicia DellaFortuna as Chief Financial Officer, effective January 1, 2025, replacing Heather Stark who will depart on December 27, 2024. DellaFortuna brings significant financial leadership experience, having previously served as CFO at Enthusiast Gaming and BuzzFeed, where she drove operational efficiency and profitability. At BuzzFeed, she led key acquisitions including Complex Networks and HuffPost, while diversifying revenue streams. The appointment comes during what the company describes as a critical transformation period as it adapts to rapidly evolving industry conditions.
WW International reported Q3 2024 results with revenues of $192.9 million, down 10.2% year-over-year. The company posted an operating loss of $39.0 million compared to operating income of $30.6 million in the prior year. End of Period Subscribers decreased 8.8% to 3.7 million. Clinical Subscribers grew 71.5% to 78,000. Adjusted gross margin improved to 69.1%. The company recorded non-cash impairment charges of $57.0 million for franchise rights. WW reiterated its full year 2024 guidance, expecting year-end subscribers of at least 3.1 million and revenue of at least $770.0 million.
WW International (NASDAQ: WW) has announced it will release its third quarter 2024 financial results before market open on Wednesday, November 6, 2024. The company will host a conference call at 8:30 a.m. ET on the same day, featuring Interim President and CEO Tara Comonte and CFO Heather Stark, who will discuss the results and address questions from investors. A live webcast will be available on corporate.ww.com, along with supplemental investor materials, and will remain accessible for approximately 90 days.
WeightWatchers (NASDAQ: WW) has announced the addition of compounded semaglutide to its weight management program, starting at $129. This expansion aims to enhance accessibility and affordability of weight loss medications amid ongoing shortages of branded GLP-1 drugs. The company's offering combines clinical interventions with behavioral support, including access to board-certified clinicians, registered dietitians, and the WeightWatchers community.
Key points:
- WeightWatchers partnered with an FDA-registered 503B facility to ensure quality and safety
- The company conducted nearly 3 million stock checks, finding GLP-1 medications in stock only 4.5% of the time
- 45% of eligible WeightWatchers Clinic members were denied insurance coverage for GLP-1 medications
- Members using GLP-1 medications with the Points® Program lose 11% more weight than those using medications alone
- Compounded semaglutide will be available to eligible members within 1-3 business days
WeightWatchers (NASDAQ: WW) announced a significant leadership change on Sept. 27, 2024. Tara Comonte, an independent board member, has been appointed as Interim Chief Executive Officer, succeeding Sima Sistani, who is stepping down from her roles as CEO and board member.
During her tenure, Sistani led the company's transformation into a modern digital health organization and expanded its portfolio with the acquisition of Sequence (now WeightWatchers Clinic). Comonte, with her extensive executive leadership experience, is expected to guide the company's transformation, sharpen its strategic focus, and evolve its offerings to drive growth.
The company reaffirmed its full-year 2024 guidance for End of Period Subscribers, Revenue, Adjusted Operating Income, and Adjusted EBITDAS. The WeightWatchers Board of Directors has been reduced from nine to eight members following this transition.
WeightWatchers (NASDAQ: WW) has announced two strategic leadership appointments to drive growth and community engagement. Scott Honken joins as Chief Commercial Officer, overseeing B2B growth, operations, partnerships, and licensing. Phillip Picardi becomes Chief Impact Officer, focusing on building communities and scaling the company's impact work.
Honken, formerly at Calibrate, brings experience from Rightway and Livongo in forming multimillion-dollar partnerships. Picardi, previously Chief Strategy Officer at the Los Angeles LGBT Center, will lead brand marketing, communications, social impact, and employee experience teams.
These appointments align with WeightWatchers' goal to expand access to equitable care and redefine community engagement across all stakeholders, including employers, payers, and health plans.
WW International, Inc. (NASDAQ: WW) announced its Q2 2024 financial results. The company reported revenues of $202.1 million, down 10.9% YoY, with a gross margin of 67.9%. Operating income rose 36.5% to $35.9 million, while adjusted operating income increased 12% to $37.9 million. However, net income dropped 54.2% to $23.3 million, and EPS fell 54.9% to $0.29. End of period subscribers declined 6.1%, with Digital subscribers and Workshops + Digital subscribers decreasing by 4.2% and 21.4%, respectively. The company launched a 2024 restructuring plan to save $100 million annually through operational optimization.
For 2024, WW expects revenues of at least $770 million and adjusted operating income of at least $100 million.
WW International, Inc. (NASDAQ: WW), also known as WeightWatchers, has announced its upcoming second quarter 2024 earnings release and conference call. The company will disclose its Q2 2024 results before the market opens on Thursday, August 1, 2024. Following this, WeightWatchers will host a conference call at 8:30 a.m. ET on the same day.
During the call, CEO Sima Sistani and CFO Heather Stark will discuss the quarterly results and address questions from investors. The event will be accessible via a live webcast on the company's corporate website, where supplemental investor materials will also be available. A replay of the webcast will remain accessible for approximately 90 days after the event.
WW International, Inc. announced its Q1 2024 results, with 4.0 million subscribers and $206.5 million in revenues. The company reported a gross margin of 66.7%, operating loss of $269.3 million due to non-cash intangible impairment charges, and provided full-year guidance. End of period subscribers were down 0.4% year-over-year, while digital subscribers increased by 0.7%. Gross profit was $137.8 million, with adjusted gross profit at $140.3 million. Operating loss was $269.3 million but adjusted to $5.6 million. Net loss was $347.9 million, and the company had a cash balance of $66.6 million as of March 30, 2024.
WeightWatchers for Business has partnered with Personify Health to offer employers integrated access to WeightWatchers' full-spectrum weight health platform. This collaboration aims to provide customizable weight health solutions for organizations using Personify Health's personalized health platform, offering a range of interventions from behavioral to medical for users based on clinical needs. The partnership combines WeightWatchers' science-backed programs with Personify Health's comprehensive health ecosystem to address weight health care needs effectively.